A longitudinal brain magnetic resonance imaging study of neuromyelitis optica spectrum disorder

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Kim, Su Hyun ^a   Huh, So Young ^b   Hyun, Jae Won ^a   Jeong, In Hye ^a   Lee, Sang Hyun ^a   Joung, AeRan ^a   Kim, Ho Jin ^a  

^a National Cancer Center   (South Korea)

^b Kosin University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; IMMUNOSUPPRESSIVE AGENT;

ACUTE DISEASE; ADULT; ARTICLE; BASAL GANGLION; BRAIN DAMAGE; BRAIN FOURTH VENTRICLE; BRAIN SIZE; CEREBELLUM INJURY; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYELOOPTIC NEUROPATHY; NEUROMYELITIS OPTICA SPECTRUM DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRESCHOOL CHILD; PYRAMIDAL TRACT; SCHOOL CHILD; SYMPTOM; WHITE MATTER LESION; ADOLESCENT; BRAIN; DRUG EFFECTS; NEUROMYELITIS OPTICA; PATHOLOGY; WHITE MATTER; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN; CHILD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; WHITE MATTER; YOUNG ADULT;

EID: 84907429995     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108320     Document Type: Article

References (38)

1. Bichuetti DB, Rivero RL, Oliveira DM, Souza NA, Abdala N, et al. (2008) Neuromyelitis optica: brain abnormalities in a Brazilian cohort. Arq Neuropsiquiatr 66: 1-4.
2. Cabrera-Gomez J, Saiz-Hinarejos A, Graus F, González-Quevedo A, Rodríguez-Rojas R, et al. (2008) Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders. Mult Scler 14: 248-251.
3. Cabrera-Gomez JA, Kister I (2012) Conventional brain MRI in neuromyelitis optica. Eur J Neurol 19: 812-819.
4. Kim W, Kim SH, Huh SY, Kim HJ (2012) Brain abnormalities in neuromyelitis optica spectrum disorder. Mult Scler Int 2012: 735486.
5. Kim W, Kim SH, Kim HJ (2011) New insights into neuromyelitis optica. J Clin Neurol 7: 115-127.
6. Kim W, Park MS, Lee SH, Kim SH, Jung IJ, et al. (2010) Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin- 4 autoimmunity. Mult Scler 16: 1229-1236.
7. Matsushita T, Isobe N, Matsuoka T, Ishizu T, Kawano Y, et al. (2009) Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions. Mult Scler 15: 1113-1117.
8. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, et al. (2006) Brain abnormalities in neuromyelitis optica. Arch Neurol 63: 390-396.
9. Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, et al. (2011) Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology 76: 1229-1237.
10. Saiki S, Ueno Y, Moritani T, Sato T, Sekine T, et al. (2009) Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica. J Neurol Sci 284: 217-219.
11. Kim W, Kim SH, Lee SH, Li XF, Kim HJ (2011) Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler 17: 1107-1112.
12. Moore GR, Leung E, MacKay AL, Vavasour IM, Whittall KP, et al. (2000) A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain. Neurology 55: 1506-1510.
13. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489
14. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6: 805-815.
15. Kim W, Lee JE, Li XF, Kim SH, Han BG, et al. (2012) Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4. Mult Scler 18: 578-86.
16. Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, et al. (2010) Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 291: 52-56.
17. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107-1114.
18. Nakamura M, Misu T, Fujihara K, Nakashima I, Takahashi T, et al. (2009) Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult Scler 15: 695-700.
19. Magana SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, et al. (2009) Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 72: 712-717.
20. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, et al. (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130: 1194-1205.
21. Kim SH, Kim W, Kook MC, Hong EK, Kim HJ (2012) Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality. Mult Scler 18: 1340-1343.
22. Nakamura M, Endo M, Murakami K, Konno H, Fujihara K, et al. (2005) An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion. Mult Scler 11: 735-738.
23. Makino T, Ito S, Mori M, Yonezu T, Ogawa Y, et al. (2013) Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica. Mult Scler 19: 308-315.
24. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, et al (2007). Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130: 1224-1234.
25. Pichiecchio A, Tavazzi E, Poloni G, Ponzio M, Palesi F, et al. (2012) Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach. Mult Scler 18: 817-824.
26. Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, et al. (2008) Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 205: 2473-2481.
27. Tang H, Brimijoin S (2001) Complement regulatory proteins and selective vulnerability of neurons to lysis on exposure to acetylcholinesterase antibody. J Neuroimmunol 115: 53-63.
28. Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, et al. (2009) Prediction of neuromyelitis optica attack severity by quantitation of comple-ment- mediated injury to aquaporin-4-expressing cells. Arch Neurol 66: 1164-1167.
29. Hinson SR, Romero MF, Popescu BF, Lucchinetti CF, Fryer JP, et al. (2012) Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci USA 109: 1245-1250.
30. Lassmann H (2008) The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Neuroimaging Clin N Am 18: 563-576, ix.
31. Miller DH, Rudge P, Johnson G, Kendall BE, Macmanus DG, et al (1988). Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 111: 927-939.
32. Kister I, Ge Y, Herbert J, Sinnecker T, Wuerfel J, et al. (2013) Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 81: 1966.
33. Raz E, Loh JP, Saba L, Omari M, Herbert J, et al. (2014) Periventricular lesions help differentiate neuromyelitis optica spectrum disorders from multiple sclerosis. Mult Scler Int 2014: 986923.
34. Matthews L, Marasco R, Jenkinson M, Küker W, Luppe S, et al. (2013) Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 80: 1330-1337.
35. Sinnecker T, Dörr J, Pfueller CF, Harms L, Ruprecht K, et al. (2012) Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 79: 708-714.
36. Kister I, Herbert J, Zhou Y, Ge Y(2013) Ultrahigh-Field MR (7T) imaging of brain lesions in neuromyelitis optica. Mult Scler Int 2013: 398259.
37. Sahraian MA, Radue EW, Haller S, Kappos L (2010) Black holes in multiple sclerosis: definition, evolution, and clinical correlations. Acta Neurol Scand 122: 1-8.
38. Hickman SJ, Brierley CM, Silver NC, Moseley IF, Scolding NJ, et al. (2001) Infratentorial hypointense lesion volume on T1-weighted magnetic resonance imaging correlates with disability in patients with chronic cerebellar ataxia due to multiple sclerosis. J Neurol Sci 187: 35-39.